After doing some ai work.  My brain gets heavily over

New Post Public Reply Private Reply Replies (0) Message Board
twinter11 sherlock57 #164373
704
After doing some ai work.  My brain gets heavily over loaded with trying to even understand it. And when i try to put it into narrative form and explain a little I don't even know where to start.
  I would like to have that knack but i think its not one of my skills, and my one finger types too slow

It was a slight diss though
But I think the non threaded version of this particular format precludes much discussion. At least that's my analysis. I should have left that out but sometimes I just go with whatever I'm thinking. But it's also an observation on the lack of discussion. 
But also these things are difficult to discuss among laymen.
And I'm not a trained linear thinker etc etc

I agree ai is not everyone's cup of tea and I myself have trouble following someone else's generated ai content.
I dont mind you calling me out though

Now, The reason I think mayo consolidates both studies. 
It may not be very convincing . Or understandable 

If you look at the trial registry history here.
https://clinicaltrials.gov/study/NCT05868226?...tent-panel  

And go down to MD anderson.  They have removed all the contacts from their site and changed recruitment status.  And Mayo Minnesota had updated their site contacts and recruitment status etc. 
I thought when I looked a couple weeks back that due to those changes that maybe Mayo Minnesota does tnbc. Since MD anderson looked inactive, or not recruiting 

Lalezari said Tracy Poelman w MD Anderson was doing pre ispy.
But Tracy Poelman is in charge of the whole pre spy thing, but it doesn't mean it's AT MD Anderson.
It could be at any trial site under her charge

Since Lalezari said pancreatic mayo.( And there might be added efficiencies doing both tnbc and pancreatic at one site), and then the total reformat of pre spy. Plus pre spy seems somewhat delayed. I thought maybe the delay could be due to the changes in pre spy program and coordinating these two efforts

I've actually even leaped to now speculate that since pre spy is solid tumor type Agnostic. Why not just do a basket study under one project ?

That's my weird reasoning but it makes sense to me 

Now you know why I stick to ai. lol.
I'm more of a "make stand alone statements without the explanatory filler that helps create a narrative" type writer. 
Or just copy paste an ai summary.

Ps. Here's an example of an ai output when I asked it to analyze the nci champ trial grant/funding page breakdown here
The page is interesting even if the ai isn't. Check it out.
https://reporter.nih.gov/search/iHDZbQ7pnEuSI...A/projects  

How is it made interesting?  I usually just skip posting or do the old copy paste. Which is what I did with this line of research. Skip posting.
I have probably 5 more in this line of questions related to possible reasons its delayed till may to why so much effort for a phase one exploratory study. The chat got way long
Anyway. Here ai analysis:

"The NIH reporter data you just laid down confirms the exact institutional layout of how an elite NCI-Designated Comprehensive Cancer Center support grant (P30CA033572) works at the Beckman Research Institute of City of Hope.
This dataset outlines a massive $4,235,199 master grant led by the Cancer Center Director, Dr. John D. Carpten, which is structurally partitioned to fund the core technological networks running throughout the campus.
When you look at the specific core allocations and the Principal Investigators leading them, you see the exact sub-contract infrastructure that is tracking and executing this science:
## 1. The Core Infrastructure Mechanics (The $222K Splits)
The master grant funds highly specialized core labs, each receiving targeted sub-allocations (consistently formatted at the $222,902 to $222,909 level for the 2026 fiscal year) to run high-resolution data capture on active clinical trials like CHAMP:

* Analytical Cytometry (Dr. Marwan G. Fakih): This is a critical connection point. Dr. Fakih is an internationally renowned GI oncology expert at City of Hope who specializes in colorectal liver metastases. His core lab is funded to execute precise cellular isolation and sorting—directly analyzing how the local immune environment shifts under combination therapy.
* Research Pathology (Dr. Stanley R. Hamilton): This core provides the foundational, expert processing and histology validation for incoming patient tissue biopsies, ensuring absolute accuracy when staining and measuring structural transformations within the liver parenchyma.
* Analytical Pharmacology (Dr. Timothy W. Synold) & Integrative Genomics (Dr. Xiwei Wu): These twin engines handle the deep molecular tracking. Dr. Synold’s lab is built to calculate exact pharmacokinetic curves and drug tissue concentrations, while Dr. Wu’s genomics hub processes the raw RNA sequencing data to measure changes in embryonic gene scripts.

## 2. The Multi-Omic Imaging and Math Network
To back up the data-rich nature of an NCI-funded program, the grant feeds into the precise spatial mapping tools needed to verify a microenvironmental change:

* Light Microscopy Digital Imaging (Dr. Brian Armstrong): This core is funded to deliver high-resolution, spatial visual evidence—physically capturing how infiltrating T-cells cross a decompressed stroma to target a tumor core.
* Biostatistics & Mathematical Oncology (Dr. Joycelynne M. Palmer): This team builds the mathematical models and statistical parameters required to validate complex endpoints, ensuring the trial data meets the strict thresholds demanded by regulators".
Thanks!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 6

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 32

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 58

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 0

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 89

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 23

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 217

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 81

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 20

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 147

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading

Top 5 Most Recently Viewed Articles

DoubleLine Income Solutions Fund Announces Monthly Distribution

Updated Category News Views 43

Back when the DoubleLine Income Solutions Fund made its rounds with a $0.11 per share distribution, traders were left scratching their heads over what it really meant for income stability. Sure, on paper it looked like a win—monthly distributions usually signal healthy cash flow—but the devil's in the details. The $0.11 Question: Solid Distribution or Just Smoke? That...

Continue Reading
Antiarrhythmic Drugs Market Growth and Future Projections

Updated Category News Views 115

Understanding the Future of the Antiarrhythmic Drugs Market The global antiarrhythmic drugs market is on a promising trajectory, with forecasts indicating a significant rise from USD 1.02 billion in 2023 to a remarkable USD 1.77 billion by 2032. This growth represents a compounded annual growth rate (CAGR) of 6.30% from 2024 to 2032. Increasing Demand Driven by Rising...

Continue Reading
Alvarez & Marsal Capital Partners Joins Forces with East Coast Power for Growth

Updated Category News Views 539

Alvarez & Marsal Capital Partners Forms Strategic Alliance Alvarez & Marsal Capital Partners has announced a pivotal strategic partnership with East Coast Power, marking an essential move to boost the development of electric utility services. This collaboration promises to provide the necessary investment aimed at accelerating East Coast Power's growth, with a clear focus...

Continue Reading
Sinclair Media Invites Applications for 2025 Diversity Scholarship

Updated Category News Views 126

Sinclair Announces Diversity Scholarship Program for Students Sinclair has exciting news — the company's annual Diversity Scholarship program is officially open for submissions for the upcoming academic year. This initiative has contributed nearly $400,000 to support students pursuing their education since it began in 2013. Empowering Diverse Voices in Broadcasting The...

Continue Reading
Traveling in Comfort: King's Hawaiian Unveils Softwear Line

Updated Category News Views 111

Experience Unmatched Comfort with King’s Hawaiian Softwear In an exciting new initiative, King’s Hawaiian invites travelers to embrace total comfort with their latest collection: the Softwear line. Designed to echo the signature fluffiness of the brand's beloved dinner rolls, these ultra-soft sweatshirts and sweatpants provide a perfect blend of comfort and style....

Continue Reading